Mission Statement

The Respiratory Physiology Laboratory of the University of Cyprus Medical School aims to develop and provide high quality diagnostic and clinical services to respiratory patients from Cyprus and abroad. Furthermore, the Respiratory Physiology Laboratory is involved in the educational activities of the Medical school and carries out innovative research in the fields of diagnostics, prophylaxis and treatment of respiratory diseases as well as in environmental and public health.

Moreover, the Respiratory Physiology Laboratory, in collaboration with the Cyprus Institute of Neurology and Genetics and the Archbishop Makarios III Hospital, hosts the national Primary Ciliary Dyskinesia Service (PCD Service) and offers state of the art diagnostic and clinical services to PCD patients.

The Respiratory Physiology Laboratory is a RespiHub (link to https://ucy-respihub.org) founding member laboratory.

Basic Activities

Provide training for the students of the University of Cyprus Medical School.

Development of innovative research in the fields of diagnostics, prophylaxis and treatment of respiratory diseases.

Explore novel approaches and inform policy making in the fields of environmental and public health.

Participation in international studies for respiratory diseases and for environmental and public health through the collaboration with other academic and research institutes in Cyprus and abroad.

The organization of public awareness events regarding the effect of environmental or lifestyle factors on public health and more specifically on respiratory diseases.

Primary Ciliary Dyskinesia

Primary Ciliary Dyskinesia (PCD) is a rare, genetically heterogeneous disorder which results from the dysfunction of small hair-like organelles, called motile cilia. Motile cilia project from the apical side of epithelial cells that line up the upper and lower airways (respiratory cilia) and can be found in a variety of other tissues. PCD patients usually suffer from recurrent respiratory infections which lead to chronic destructive airway disease characterized by progressive loss of lung function and structural damage to the airways (bronchiectasis).

Everything you need to know about PCD

Our Latest News

News regarding PCD and research programme results

Desert Dust Storms and the ability for accurate and timely forecasting

Our laboratory and LIFE MEDEA collaborator, Dr Petros Mouzourides, discusses about Desert Dust Storms, the available arsenal of meteorological forecasting tools as well as the online warning dissemination platform developed by LIFE MEDEA which particularly aims for timely and accurate public warnings in advance of Desert Dust Storms.

Read More

The Respiratory Physiology Laboratory participated in the final meeting of the BEAT-PCD COST Action.

The Respiratory Physiology Laboratory and the Primary Ciliary Dyskinesia Service, participated in the final meeting of the COST Action: BEAT-PCD (Better Experimental Approaches to treat PCD), which took place in Poznan, Poland between 26th and 29th of March 2019. During the meeting, the recent study of our laboratory was presented, titled “Development and psychometric validation of the Greek version of the adult QOL-PCD questionnaire: preliminary results”. The study was awarded the best study award in the field of clinical research.

2nd annual LIFE MEDEA project meeting

Several members of our laboratory, participated in the 2nd annual meeting of the LIFE MEDEA project, which took place in Heraklion, Crete (29-30 November 2018). During the meeting, the progress of LIFE MEDEA was assessed while the public had the opportunity to learn more about the health effects of Desert Dust Storms through a series of lectures by a number of prominent scientists with significant experience in the study of Desert Dust Storms affecting the Mediterranean and other regions.


Respiratory Physiology Laboratory Medical Research - Newsletter Subscription

Affiliated Institutions/Collaborators

RPL Medical Research Team